Results

Total Results: 1,070 records

Showing results for "analyze".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
    September 01, 2019 - need is technical, and pertains to developing a unified way to represent, manipulate, describe, meta-analyze … Mathematical graphs are a very versatile modeling tool,15 and they are used to describe, analyze, and
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in surveillance reports for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number …
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
    January 01, 2024 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_executive.pdf
    October 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - • To the extent that we can, we will collect and analyze data by various subgroups, including disease … considering for this review. 2) For our population of interest, we have added a statement that we will analyze … We will analyze the data assuming both homogeneous variance and heterogeneous variance.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - colon cancer for inclusion in the report, when possible (as permitted by the reported data), we will analyze … of the rectal tumor—low, middle, or high—may also affect staging accuracy, so when possible we will analyze … and distal colon cancer may also be distinctly different conditions; so if possible, we will try to analyze … For studies of test performance, we will meta-analyze the data reported by the studies using a bivariate … midas” command.31 In cases in which a bivariate binomial regression model cannot be fit, we will meta- analyze
  11. effectivehealthcare.ahrq.gov/products/childhood-cancer-survivorship-care/research
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    October 08, 2025 - G-1. Additions to ROB Template Table G-2. Additions to risk of bias template Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
    May 02, 2025 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - The analyses have been revised to analyze these groups separately. … analysis where they combined the data across all patient populations The analyses have been revised to analyze … We have revised KQ3 to analyze 3 separated groups: NPPV used to wean from invasive ventilation, NPPV … We have revised KQ3 to analyze 3 separated groups: NPPV used to wean from invasive ventilation, NPPV
  16. effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
    January 01, 2013 - Slide 1 Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research …
  17. effectivehealthcare.ahrq.gov/health-topics/peritoneal-disorders
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  19. effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
    October 08, 2025 - Using Collaborative Platforms for Communities of Practice INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE SPEAKER: LAKSHMI GRAMA, SENIOR DIGITAL CONTENT STRATEGIST, NATIONAL CANCER INSTITUTE (NCI) GRAMA: I’m Lakshmi Grama from the Office of Communications and Education at the National …
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - Layout 1 Background Anemia (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated for lymphoma. Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of anemia. For example, among pa…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: